View in EDS HTML Full Text PDF Full Text

SSTNIV, a syndecan-1-targeting peptide chimera, reverses immune suppression and inhibits myeloma progression.

Saved in:
Bibliographic Details
Title: SSTNIV, a syndecan-1-targeting peptide chimera, reverses immune suppression and inhibits myeloma progression.
Authors: Jung O; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA. ojung@unmc.edu.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA. ojung@unmc.edu.; Department of Human Oncology and School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA. ojung@unmc.edu., Beauvais DM; Department of Human Oncology and School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.; Norcliffe Foundation Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA., Ibaan GL; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA., Wooldrik CC; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA., Flietner E; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, USA., Choi S; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA. schoi@unmc.edu.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA. schoi@unmc.edu., Zhang J; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, USA., Rapraeger AC; Department of Human Oncology and School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2026 May 12; Vol. 11 (1). Date of Electronic Publication: 2026 May 12.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42115585
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: SSTN<subscript>IV</subscript>, a syndecan-1-targeting peptide chimera, reverses immune suppression and inhibits myeloma progression.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jung+O%22">Jung O</searchLink>; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA. ojung@unmc.edu.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA. ojung@unmc.edu.; Department of Human Oncology and School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA. ojung@unmc.edu.<br /><searchLink fieldCode="AU" term="%22Beauvais+DM%22">Beauvais DM</searchLink>; Department of Human Oncology and School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.; Norcliffe Foundation Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Ibaan+GL%22">Ibaan GL</searchLink>; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.<br /><searchLink fieldCode="AU" term="%22Wooldrik+CC%22">Wooldrik CC</searchLink>; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.<br /><searchLink fieldCode="AU" term="%22Flietner+E%22">Flietner E</searchLink>; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Choi+S%22">Choi S</searchLink>; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA. schoi@unmc.edu.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA. schoi@unmc.edu.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Rapraeger+AC%22">Rapraeger AC</searchLink>; Department of Human Oncology and School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101676423%22">Signal transduction and targeted therapy</searchLink> [Signal Transduct Target Ther] 2026 May 12; Vol. 11 (1). <i>Date of Electronic Publication: </i>2026 May 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101676423 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-3635 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220593635%22">20593635 </searchLink><i>NLM ISO Abbreviation: </i>Signal Transduct Target Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42115585
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41392-026-02709-1
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: SSTNIV, a syndecan-1-targeting peptide chimera, reverses immune suppression and inhibits myeloma progression.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jung O
      – PersonEntity:
          Name:
            NameFull: Beauvais DM
      – PersonEntity:
          Name:
            NameFull: Ibaan GL
      – PersonEntity:
          Name:
            NameFull: Wooldrik CC
      – PersonEntity:
          Name:
            NameFull: Flietner E
      – PersonEntity:
          Name:
            NameFull: Choi S
      – PersonEntity:
          Name:
            NameFull: Zhang J
      – PersonEntity:
          Name:
            NameFull: Rapraeger AC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 05
              Text: 2026 May 12
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2059-3635
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Signal transduction and targeted therapy
              Type: main
ResultId 1